Company news_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

08-01

Analysis of the Features ofInnoModels’ADCC Platform

In the field of biomedicine, antibody-dependent cell-mediated cytotoxicity (ADCC), as a key mechanism in tumor immunotherapy, has always attracted the attention of many researchers. In order to meet the growing research needs, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully built an in vitro pharmacodynamics platform, among which the ADCC platform has won wide recognition in the industry with its unique features and advantages. This article will introduce in detail several major features of InnoModels' ADCC platform.

07-30

What are the characteristics of the in vitro killing experimental platform of InnoModels Biotechnology Company

In the fields of life science research and drug development, in vitro killing experimental platforms are important tools for evaluating drug efficacy and studying cellular mechanisms. InnoModels Biotechnology (Beijing) Co., Ltd., with its strong research and innovation capabilities, has launched multiple in vitro killing experimental platforms, providing researchers with highly controllable and accurate experimental environments, greatly promoting the development of this field. This article will provide a detailed introduction to the characteristics of the InnoModels organism in vitro killing experimental platform.

07-29

In vivo tumor experimental platform of InnoModels Biotechnology: Detailed explanation of features and advantages

In the vast field of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the field of cancer research and treatment with its innovative in vivo tumor experimental platform. With its unique technical advantages and comprehensive service system, this platform provides researchers with unprecedented experimental conditions and tools, greatly promoting the progress of cancer medicine.

07-26

InnoModels Biotechnology ELISpot platform: a precise, efficient and multi-functional immune research tool

In the vast universe of life science research, immunology research has always occupied a pivotal position. InnoModels Biotechnology (Beijing) Co., Ltd. relies on its cutting-edge ELISpot platform to provide researchers in this field with strong technical support and solutions. This article will deeply explore the characteristics of InnoModels' ELISpot platform and demonstrate its unique charm in immunology research.

< 1...10 11 12...61 >

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License